Association of rs6498169 stratified on anti-CCP status in patients with RA
| Cases vs controls G vs A | Cases only G vs A | |||||||
|---|---|---|---|---|---|---|---|---|
| n | A | G | MAF | OR (95 % CI) | p Value | OR (95 % CI) | p Value | |
| Controls | 2110 | 2706 | 1514 | 35.9 | 1.00 | |||
| Anti-CCP+ | 454 | 566 | 342 | 37.7 | 1.08 (0.93 to 1.25) | 0.3 | 1.00 | |
| Anti-CCP− | 283 | 317 | 249 | 44.0 | 1.40 (1.18 to 1.68) | 2×10−4 | 1.30 (1.05 to 1.61) | 0.016 |
Anti-CCP, anti-cyclic citrullinated peptide; MAF, minor allele frequency; RA, rheumatoid arthritis.